title: Augmentin (intravenous then oral) compared with cefuroxime followed by cephalexin for chest infections in hospitalised patients.
authors.forename: C
authors.initials: C
authors.lastname: O'Donovan
authors.forename: R
authors.initials: R
authors.lastname: Rudd
authors.forename: S
authors.initials: S
authors.lastname: O'Neill
authors.forename: M X
authors.initials: MX
authors.lastname: Fitzgerald
authors.forename: W
authors.initials: W
authors.lastname: McNicholas
authors.forename: S G
authors.initials: SG
authors.lastname: Flavell-Matts
authors.forename: F
authors.initials: F
authors.lastname: Howell
authors.forename: A
authors.initials: A
authors.lastname: McKenzie
authors.forename: J
authors.initials: J
authors.lastname: Whittaker
mesh_terms: D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D002444:Cefuroxime / Q000008:administration & dosage / Q000627:therapeutic use*; D002506:Cephalexin / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D002969:Clavulanic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000188:drug therapy*
chemical_list: D002511:Cephalosporins; D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D002444:Cefuroxime; D002506:Cephalexin